BioVie Shares Rise 11% Ahead of Call to Discuss Trial Results

1 min read
72 views

By Ben Glickman

Shares of BioVie rose Monday ahead of the company presenting trial data for its treatment for Alzheimer’s Disease.

The stock was up 12%, to $3.58, in afternoon trading, bouncing off a 52-week low last week. Shares have fallen 54% this year.

The…

Read the full article here

Leave a Reply

Your email address will not be published.

Previous Story

Paycheck advance apps: the risks—and costs—can be high

Next Story

‘Zombie’ companies already make up 11.5% of U.S. listed stocks

Latest from Investment